FouldsGShepardRMJohnsonRB.The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother1990;25 (suppl A):73–82.
2.
GirardAEGirardDEnglishARGootzTDCimochowskiCRFaiellaJA.Pharmacokinetic and in vivo studies with azithromycin (CP-62, 993), a new macrolide with an extended half-life and excellent tissue distribution. Antimicrob Agents Chemother1987;31:1948–54.
3.
LassusA.Comparative study of azithromycin in skin and soft-tissue infections and sexually transmitted infections by Neisseria and Chlamydia species, J Antimicrob Chemother1990;25 (suppl. A):115–21.
4.
SteingrimmsonOOlafssonJHThorarinssonHRyanRWJohnsonRBTiltonRC.Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother1990;25 (suppl A):109–14.
5.
GumpDWGibsonMAshikagaT.Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women. Am J Obstet Gynecol1983;146:153–9.
6.
JonesRBArderyBRHuiSLClearyRE.Correlation between serum antichlamydial antibodies and tubal factor as a cause of infertility. Fertil Steril1982;38:553–8.
7.
MiettinenASaikkuPJanssonEPaavonenJ.Epidemiologic and clinical characteristics of pelvic inflammatory disease associated with Mycoplasma hominis, Chlamydia trachomatis, and Neisseria gonorrhoeae. Sex Transm Dis1986;13:24–8.
8.
MiettinenAHeinonenPKTeisalaKHakkarainenKPunnonenR.Serologic evidence for the role of Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma hominis in the etiology of tubal factor infertility and ectopic pregnancy. Sex Transm Dis1990;17:10–14.
9.
MooreDEFoyHMDalingJR.Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet1982;ii:574–7.
